Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,177.80
+2.40 (0.20%)
Oct 29, 2026, 10:50 AM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 163.41 billion as of October 28, 2026. It is the 7,263rd most valuable company in the world and the 415th biggest in India. Its market cap has decreased by 26.33% in one year.
Market Cap
163.41B
Enterprise Value
185.13B
Revenue
33.15B
Global Rank
Country Rank
#415 India
PE Ratio
22.97
ChartMarket Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 163.41B, an increase of 97.57%. That is a compound annual growth rate of 7.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2026 | 163.41B | -20.32% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Emcure Pharmaceuticals | 357.24B |
| Wockhardt | 318.14B |
| Piramal Pharma | 312.96B |
| Cohance Lifesciences | 187.63B |
| Alivus Life Sciences | 172.13B |
| Alembic Pharmaceuticals | 156.46B |
| NATCO Pharma | 156.18B |
| Sudeep Pharma | 128.15B |